{"data":{"filter_options":{"titles":[{"name":"Partner","value":"Partner"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Attorney","value":"Attorney"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":2839},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Atlanta's John Marshall Law School","value":2830},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Bond University","value":2841},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Bucerius Law School, Germany","value":2898},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"Chicago-Kent College of Law","value":3050},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"College of Law, Guildford, UK","value":2646},{"name":"College of Law, London, UK","value":2647},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"Delhi University","value":3099},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Durham University","value":2708},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Elisabeth Haub School of Law at Pace University","value":2936},{"name":"ELTE University Budapest","value":2969},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":3039},{"name":"Faculty of Law","value":2944},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce School of Law","value":2259},{"name":"Free University Berlin","value":2903},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"Fudan University","value":2986},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Guildhall University, London","value":2863},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"Inns of Court School of Law, UK","value":2649},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johannes Gutenberg-University, Mainz, Germany","value":2653},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"King Saud University College of Law \u0026 Political Sciences","value":2823},{"name":"King's College London","value":2987},{"name":"King's College, University of London, UK","value":2654},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Leiden University","value":2926},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"Liverpool University, UK","value":2657},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"London School of Economics and Political Science, UK","value":2658},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Ludwig Maximilian University of Munich","value":3105},{"name":"Lund University","value":3084},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Monash University, Australia","value":3047},{"name":"Monash University, Australia","value":2660},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"New York University School of Law","value":2715},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Oxford University, UK","value":2669},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queen's University Faculty of Law","value":2801},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Saint Louis University School of Law","value":2725},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Sciences Po Paris","value":2925},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Manchester","value":2845},{"name":"The University of Melbourne","value":2836},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Texas School of Law","value":2752},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad del Rosario, Bogotá Colombia","value":2677},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Iberoamericana","value":2915},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"Université Catholique de Louvain, Licencie en Droit","value":3213},{"name":"Universite Libre de Bruxelles, Belgium","value":2679},{"name":"Université Paris I Panthéon-Sorbonne","value":2680},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University College London, UK","value":2760},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Augsburg","value":2779},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of Bonn, Germany","value":2682},{"name":"University of Bristol, UK","value":2761},{"name":"University of Buenos Aires, Argentina","value":2683},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Cambridge, UK","value":2684},{"name":"University of Canterbury","value":2981},{"name":"University of Cape Town, South Africa","value":2854},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Cologne, Germany","value":2885},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of Deusto, Spain","value":2685},{"name":"University of East Anglia","value":3000},{"name":"University of East London","value":2963},{"name":"University of Exeter, UK","value":2770},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Florida, Levin College of Law","value":3112},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Hamburg, Germany","value":2688},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois at Chicago School of Law","value":2202},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kent at Canterbury, UK","value":2690},{"name":"University of Kent","value":2849},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Law","value":2954},{"name":"University of Leeds School of Law","value":2850},{"name":"University of Lethbridge","value":3030},{"name":"University of Lima","value":2859},{"name":"University of London","value":2692},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Maryland School of Law","value":2739},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":3064},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of New South Wales","value":2871},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Nottingham, England","value":2881},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Otago, New Zealand","value":2694},{"name":"University of Paris II, Pantheon-Assas, France","value":2695},{"name":"University of Paris, Pantheon Sorbonne","value":3190},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of Sheffield","value":2805},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Sydney, Australia","value":2700},{"name":"University of Tasmania","value":2835},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Tokyo","value":3153},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Turku","value":3083},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Warwick, UK","value":2771},{"name":"University of Washington School of Law","value":2412},{"name":"University of Western Australia","value":2949},{"name":"University of Wisconsin Law School","value":2755},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wollongong, Australia","value":2873},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"University Toulouse Capitol","value":3109},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"112","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"S","per_page":12,"people":[{"id":426539,"version":1,"owner_type":"Person","owner_id":4092,"payload":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"kyle-sampson","email":"ksampson@kslaw.com","phone":"+1 202 340 8202","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":6,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Sampson","nick_name":"D.","clerkships":[{"name":"Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit","years_held":"1996-1997"}],"first_name":"D.","title_rank":9999,"updated_by":202,"law_schools":[{"id":2174,"meta":{"degree":"J.D.","honors":"with honors","is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Kyle","name_suffix":"","recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}],"linked_in_url":"https://www.linkedin.com/in/kyle-sampson-4302348/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12357}]},"capability_group_id":2},"created_at":"2025-05-26T04:54:31.000Z","updated_at":"2025-05-26T04:54:31.000Z","searchable_text":"Sampson{{ FIELD }}{:title=\u0026gt;\"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America \", :detail=\u0026gt;\"U.S. Department of Justice, 2005\"}{{ FIELD }}Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.{{ FIELD }}Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization.{{ FIELD }}Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.{{ FIELD }}Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.{{ FIELD }}Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice.{{ FIELD }}With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.{{ FIELD }}Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients.{{ FIELD }}Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.{{ FIELD }}Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.{{ FIELD }}Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE).{{ FIELD }}Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.{{ FIELD }}\nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n{{ FIELD }}As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.{{ FIELD }}Kyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\n\nKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\nKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\n \n  Partner Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America  U.S. Department of Justice, 2005 Brigham Young University J. Reuben Clark Law School University of Chicago University of Chicago Law School U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Utah District of Columbia Utah Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions. Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization. Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters. Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions. Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice. With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program. Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients. Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations. Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy. Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE). Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act. \nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.","searchable_name":"D. Kyle Sampson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427262,"version":1,"owner_type":"Person","owner_id":6596,"payload":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","slug":"jeffrey-shapiro","email":"jshapiro@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":5,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Shapiro","nick_name":"Jeffrey","clerkships":[],"first_name":"Jeffrey","title_rank":9999,"updated_by":35,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"1986-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11031}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:28.000Z","updated_at":"2025-05-26T04:59:28.000Z","searchable_text":"Shapiro{{ FIELD }}{:title=\u0026gt;\"Life Sciences Key Lawyer\", :detail=\u0026gt;\"The Legal 500 (2024)\"}{{ FIELD }}{:title=\u0026gt;\"Life Science Star\", :detail=\u0026gt;\"LMG Life Sciences, 2012 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"DC Super Lawyer\", :detail=\u0026gt;\"Super Lawyers, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"The International Who’s Who of Business Lawyers – Life Sciences\", :detail=\u0026gt;\"Who’s Who Legal, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"Nominee for Regulatory Attorney of the Year\", :detail=\u0026gt;\"LMG Life Sciences, 2017\"}{{ FIELD }}Jeff has 30 years’ experience in US medical device law and regulation.  He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.  He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA’s requests for information and data.  When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.  His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.  Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA’s regulation of combination products (e.g., drug-device combinations).\nJeff is a national authority on FDA’s regulation of medical devices, combination products, and HCT/Ps.  He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA’s regulation of medical devices.\nHe is a past member of the Editorial Advisory Board for both MDDI and Update magazines, co-editor of two textbooks, Promotion of Biomedical Products (Food and Drug Law Institute, 2006) and Combination Products, How to Develop the Optimal Strategic Path for Approval (FDA News 2005).  He has contributed chapters to several textbooks, including Medical Devices Law and Regulation Answer Book (Practising Law Institute 2023 ed.).\nJeff was a Lecturer and Fischell Literati teaching the University of Maryland’s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute. Partner Life Sciences Key Lawyer The Legal 500 (2024) Life Science Star LMG Life Sciences, 2012 – 2023 DC Super Lawyer Super Lawyers, 2014 – 2023 The International Who’s Who of Business Lawyers – Life Sciences Who’s Who Legal, 2014 – 2023 Nominee for Regulatory Attorney of the Year LMG Life Sciences, 2017 Brown University  Harvard University Harvard Law School District of Columbia","searchable_name":"Jeffrey K. Shapiro","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442766,"version":1,"owner_type":"Person","owner_id":5387,"payload":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","slug":"adam-solander","email":"asolander@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":28,"guid":"28.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":5,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Solander","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":101,"law_schools":[{"id":1562,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2007-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}],"linked_in_url":"https://www.linkedin.com/in/adamsolander/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6393}]},"capability_group_id":2},"created_at":"2025-11-13T04:56:44.000Z","updated_at":"2025-11-13T04:56:44.000Z","searchable_text":"Solander{{ FIELD }}{:title=\u0026gt;\"Named to Washington DC Rising Stars list\", :detail=\u0026gt;\"Super Lawyers, 2016-2018\"}{{ FIELD }}{:title=\u0026gt;\"Received Readers’ Choice Award\", :detail=\u0026gt;\"JD Supra, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Received Burton Award for Legal Writing\", :detail=\u0026gt;\"Burton Awards Program in association with the Library of Congress, 2014\"}{{ FIELD }}As a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.\nAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\nPrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security.  He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments. \nPreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch. Partner Named to Washington DC Rising Stars list Super Lawyers, 2016-2018 Received Readers’ Choice Award JD Supra, 2016 Received Burton Award for Legal Writing Burton Awards Program in association with the Library of Congress, 2014 West Virginia University West Virginia University College of Law Pennsylvania State University Pennsylvania State University, Dickinson School of Law West Virginia University West Virginia University College of Law District of Columbia District of Columbia Bar Association Member, American Health Lawyers Association","searchable_name":"Adam C. Solander","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":448692,"version":1,"owner_type":"Person","owner_id":2860,"payload":{"bio":"\u003cp\u003eWes Steimle is counsel in King \u0026amp; Spalding's Product Liability and Mass Tort and Toxic Tort practices.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]Wes has\u0026nbsp;over 11 years of experience in handing complex cases on behalf of major pharmaceutical, petroleum, chemical, and technology companies. He focuses on the defense of cases involving product liability, premises liability, toxic torts and commercial litigation.\u003c/p\u003e","slug":"william-steimle","email":"wsteimle@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003ePharmaceutical\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in the defense of personal injury cases in state and federal courts throughout California which involve claims that plaintiffs sustained degeneration of shoulder joint cartilage (chondrolysis) as a result of the post-operative administration of anesthetic to their shoulder joints.\u003c/p\u003e","\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis, which are pending in state and federal courts in California.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eSuccessfully defended \u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e in numerous product liability actions in San Francisco, Los Angeles, and Orange Counties, in which it was alleged to be the successor to a manufacturer of the Salk polio vaccine. Wes prepared and argued successful pleadings challenges that ultimately led to the statewide dismissal of plaintiffs\u0026rsquo; claims.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eSmartHealth Inc.\u003c/strong\u003e in the defense of the latex glove product liability cases in California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLead Paint Litigation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003eAmerican Cyanamid Company\u003c/strong\u003e in a lead paint public nuisance lawsuit prosecuted by several cities and counties in California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major chemical manufacturer\u003c/strong\u003e in product liability claims based upon alleged exposure to benzene.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eUnion Oil Company of California\u003c/strong\u003e in defense of multiple personal injury claims involving alleged exposure to methyl tertiary butyl ether (MTBE).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresents \u003cstrong\u003eseveral defendants\u003c/strong\u003e in asbestos product liability and premises liability actions throughout California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCommercial Litigation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea network solutions provider\u003c/strong\u003e in defense of commercial litigation relating to the sales of its products abroad.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003ea major specialty chemicals company\u003c/strong\u003e in commercial litigation pending in federal court in the Central District of California.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eRhodia Inc.\u003c/strong\u003e in commercial litigation involving contracts covering the provision of uniforms for its employees.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eUnfair Competition/Antitrust\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in a California state action by pharmacies alleging a price-fixing conspiracy among manufacturers of brand name drugs in violation of the Cartwright Act and California's Unfair Competition Laws.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":16,"guid":"16.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":3,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Steimle","nick_name":"Wes","clerkships":[],"first_name":"William","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"E.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eWes Steimle is counsel in King \u0026amp; Spalding's Product Liability and Mass Tort and Toxic Tort practices.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]Wes has\u0026nbsp;over 11 years of experience in handing complex cases on behalf of major pharmaceutical, petroleum, chemical, and technology companies. He focuses on the defense of cases involving product liability, premises liability, toxic torts and commercial litigation.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003ePharmaceutical\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in the defense of personal injury cases in state and federal courts throughout California which involve claims that plaintiffs sustained degeneration of shoulder joint cartilage (chondrolysis) as a result of the post-operative administration of anesthetic to their shoulder joints.\u003c/p\u003e","\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis, which are pending in state and federal courts in California.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eSuccessfully defended \u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e in numerous product liability actions in San Francisco, Los Angeles, and Orange Counties, in which it was alleged to be the successor to a manufacturer of the Salk polio vaccine. Wes prepared and argued successful pleadings challenges that ultimately led to the statewide dismissal of plaintiffs\u0026rsquo; claims.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eSmartHealth Inc.\u003c/strong\u003e in the defense of the latex glove product liability cases in California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLead Paint Litigation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003eAmerican Cyanamid Company\u003c/strong\u003e in a lead paint public nuisance lawsuit prosecuted by several cities and counties in California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major chemical manufacturer\u003c/strong\u003e in product liability claims based upon alleged exposure to benzene.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eUnion Oil Company of California\u003c/strong\u003e in defense of multiple personal injury claims involving alleged exposure to methyl tertiary butyl ether (MTBE).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresents \u003cstrong\u003eseveral defendants\u003c/strong\u003e in asbestos product liability and premises liability actions throughout California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCommercial Litigation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea network solutions provider\u003c/strong\u003e in defense of commercial litigation relating to the sales of its products abroad.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003ea major specialty chemicals company\u003c/strong\u003e in commercial litigation pending in federal court in the Central District of California.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong\u003eRhodia Inc.\u003c/strong\u003e in commercial litigation involving contracts covering the provision of uniforms for its employees.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eUnfair Competition/Antitrust\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents \u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e in a California state action by pharmacies alleging a price-fixing conspiracy among manufacturers of brand name drugs in violation of the Cartwright Act and California's Unfair Competition Laws.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1202}]},"capability_group_id":3},"created_at":"2026-05-28T21:51:51.000Z","updated_at":"2026-05-28T21:51:51.000Z","searchable_text":"Steimle{{ FIELD }}Pharmaceutical\nRepresents a major pharmaceutical company in the defense of personal injury cases in state and federal courts throughout California which involve claims that plaintiffs sustained degeneration of shoulder joint cartilage (chondrolysis) as a result of the post-operative administration of anesthetic to their shoulder joints.{{ FIELD }}Represents a major pharmaceutical company in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis, which are pending in state and federal courts in California. {{ FIELD }}Successfully defended The Dow Chemical Company in numerous product liability actions in San Francisco, Los Angeles, and Orange Counties, in which it was alleged to be the successor to a manufacturer of the Salk polio vaccine. Wes prepared and argued successful pleadings challenges that ultimately led to the statewide dismissal of plaintiffs’ claims.{{ FIELD }}Successfully represented SmartHealth Inc. in the defense of the latex glove product liability cases in California.{{ FIELD }}Lead Paint Litigation\nRepresents American Cyanamid Company in a lead paint public nuisance lawsuit prosecuted by several cities and counties in California.{{ FIELD }}Toxic Tort\nRepresents a major chemical manufacturer in product liability claims based upon alleged exposure to benzene.{{ FIELD }}Successfully represented Union Oil Company of California in defense of multiple personal injury claims involving alleged exposure to methyl tertiary butyl ether (MTBE). {{ FIELD }}Represents several defendants in asbestos product liability and premises liability actions throughout California.{{ FIELD }}Commercial Litigation\nRepresents a network solutions provider in defense of commercial litigation relating to the sales of its products abroad.{{ FIELD }}Successfully represented a major specialty chemicals company in commercial litigation pending in federal court in the Central District of California.{{ FIELD }}Successfully represented Rhodia Inc. in commercial litigation involving contracts covering the provision of uniforms for its employees.{{ FIELD }}Unfair Competition/Antitrust\nRepresents a major pharmaceutical company in a California state action by pharmacies alleging a price-fixing conspiracy among manufacturers of brand name drugs in violation of the Cartwright Act and California's Unfair Competition Laws.{{ FIELD }}Wes Steimle is counsel in King \u0026amp; Spalding's Product Liability and Mass Tort and Toxic Tort practices.\nWes has over 11 years of experience in handing complex cases on behalf of major pharmaceutical, petroleum, chemical, and technology companies. He focuses on the defense of cases involving product liability, premises liability, toxic torts and commercial litigation. Counsel University of California-Santa Barbara  University of California Hastings College of Law University of California Hastings College of Law U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California State Bar of California Pharmaceutical\nRepresents a major pharmaceutical company in the defense of personal injury cases in state and federal courts throughout California which involve claims that plaintiffs sustained degeneration of shoulder joint cartilage (chondrolysis) as a result of the post-operative administration of anesthetic to their shoulder joints. Represents a major pharmaceutical company in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis, which are pending in state and federal courts in California.  Successfully defended The Dow Chemical Company in numerous product liability actions in San Francisco, Los Angeles, and Orange Counties, in which it was alleged to be the successor to a manufacturer of the Salk polio vaccine. Wes prepared and argued successful pleadings challenges that ultimately led to the statewide dismissal of plaintiffs’ claims. Successfully represented SmartHealth Inc. in the defense of the latex glove product liability cases in California. Lead Paint Litigation\nRepresents American Cyanamid Company in a lead paint public nuisance lawsuit prosecuted by several cities and counties in California. Toxic Tort\nRepresents a major chemical manufacturer in product liability claims based upon alleged exposure to benzene. Successfully represented Union Oil Company of California in defense of multiple personal injury claims involving alleged exposure to methyl tertiary butyl ether (MTBE).  Represents several defendants in asbestos product liability and premises liability actions throughout California. Commercial Litigation\nRepresents a network solutions provider in defense of commercial litigation relating to the sales of its products abroad. Successfully represented a major specialty chemicals company in commercial litigation pending in federal court in the Central District of California. Successfully represented Rhodia Inc. in commercial litigation involving contracts covering the provision of uniforms for its employees. Unfair Competition/Antitrust\nRepresents a major pharmaceutical company in a California state action by pharmacies alleging a price-fixing conspiracy among manufacturers of brand name drugs in violation of the Cartwright Act and California's Unfair Competition Laws.","searchable_name":"William E. Steimle (Wes)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":426701,"version":1,"owner_type":"Person","owner_id":5373,"payload":{"bio":"\u003cp\u003eCori C. Steinmann focuses her practice on the representation of various business clients in state and federal complex litigation matters involving products liability, toxic torts, business litigation, and construction cases.\u0026nbsp; As an active\u0026nbsp;trial lawyer, she has\u0026nbsp;successfully defended clients in\u0026nbsp;jury trials in Texas, Nevada, New Jersey, New York, Arizona, Florida, Illinois, and California. Ms. Steinmann\u0026rsquo;s aggressive approach to the defense of her clients has resulted in the early dismissal of actions, favorable settlements, and defense verdicts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLicensed in both Texas and California, Cori\u0026nbsp;has represented\u0026nbsp;numerous Fortune 100 Companies across the country\u0026nbsp;in\u0026nbsp;product liability and\u0026nbsp;toxic tort litigation.\u0026nbsp;In addition to her courtroom experience,\u0026nbsp;she has effectively handled all phases of litigation, including discovery and e-discovery, taking and defending lay and expert depositions, preparing company witnesses for deposition and trial, and drafting and arguing a wide range of pre and post-trial motions.\u0026nbsp;\u003c/p\u003e","slug":"cori-steinmann","email":"csteinmann@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":2,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":3,"source":"smartTags"},{"id":764,"guid":"764.smart_tags","index":4,"source":"smartTags"},{"id":762,"guid":"762.smart_tags","index":5,"source":"smartTags"},{"id":5,"guid":"5.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":7,"guid":"7.capabilities","index":8,"source":"capabilities"},{"id":4,"guid":"4.capabilities","index":9,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":10,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":11,"source":"capabilities"}],"is_active":true,"last_name":"Steinmann","nick_name":"Cori","clerkships":[],"first_name":"Cori","title_rank":9999,"updated_by":101,"law_schools":[{"id":1852,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2004-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eCori C. Steinmann focuses her practice on the representation of various business clients in state and federal complex litigation matters involving products liability, toxic torts, business litigation, and construction cases.\u0026nbsp; As an active\u0026nbsp;trial lawyer, she has\u0026nbsp;successfully defended clients in\u0026nbsp;jury trials in Texas, Nevada, New Jersey, New York, Arizona, Florida, Illinois, and California. Ms. Steinmann\u0026rsquo;s aggressive approach to the defense of her clients has resulted in the early dismissal of actions, favorable settlements, and defense verdicts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLicensed in both Texas and California, Cori\u0026nbsp;has represented\u0026nbsp;numerous Fortune 100 Companies across the country\u0026nbsp;in\u0026nbsp;product liability and\u0026nbsp;toxic tort litigation.\u0026nbsp;In addition to her courtroom experience,\u0026nbsp;she has effectively handled all phases of litigation, including discovery and e-discovery, taking and defending lay and expert depositions, preparing company witnesses for deposition and trial, and drafting and arguing a wide range of pre and post-trial motions.\u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6372}]},"capability_group_id":3},"created_at":"2025-05-26T04:56:09.000Z","updated_at":"2025-05-26T04:56:09.000Z","searchable_text":"Steinmann{{ FIELD }}Cori C. Steinmann focuses her practice on the representation of various business clients in state and federal complex litigation matters involving products liability, toxic torts, business litigation, and construction cases.  As an active trial lawyer, she has successfully defended clients in jury trials in Texas, Nevada, New Jersey, New York, Arizona, Florida, Illinois, and California. Ms. Steinmann’s aggressive approach to the defense of her clients has resulted in the early dismissal of actions, favorable settlements, and defense verdicts.\nLicensed in both Texas and California, Cori has represented numerous Fortune 100 Companies across the country in product liability and toxic tort litigation. In addition to her courtroom experience, she has effectively handled all phases of litigation, including discovery and e-discovery, taking and defending lay and expert depositions, preparing company witnesses for deposition and trial, and drafting and arguing a wide range of pre and post-trial motions.  Counsel The University of Texas at Austin The University of Texas School of Law Southern Methodist University Southern Methodist University Dedman School of Law Central District of California U.S. District Court for the Eastern District of Texas U.S. District Court for the Northern District of Texas U.S. District Court for the Western District of Texas California Texas","searchable_name":"Cori C. Steinmann","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null}]}}